(PFGC) Performance Food - Overview
Stock: Foodservice, Convenience, Specialty
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 26.3% |
| Relative Tail Risk | -7.57% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.27 |
| Alpha | -5.55 |
| Character TTM | |
|---|---|
| Beta | 0.758 |
| Beta Downside | 0.921 |
| Drawdowns 3y | |
|---|---|
| Max DD | 21.24% |
| CAGR/Max DD | 0.77 |
Description: PFGC Performance Food January 03, 2026
Performance Food Group Company (PFGC) distributes a broad portfolio of food and related products across North America through three operating segments-Foodservice, Convenience, and Specialty. Its catalogue spans fresh proteins (beef, pork, poultry, seafood), frozen and refrigerated items, dry groceries, cleaning supplies, snacks, beverages, health-and-beauty goods, and even nicotine products, supported by an extensive network of distribution centers and value-added services such as menu development, procurement assistance, and technology-enabled marketing programs.
Key industry drivers that influence PFGC’s outlook include: (1) **Foodservice inflation**, where rising commodity prices and labor costs have historically pressured margins but also create pricing power for distributors that can offer cost-saving solutions; (2) **Same-store sales growth**-PFGC has reported a 4-5% YoY increase in its core Foodservice segment in recent quarters, reflecting steady demand from independent and chain restaurants; and (3) **E-commerce penetration**, with the company expanding digital ordering platforms that have accelerated order frequency and improved inventory turnover, a trend seen across the broader food-distribution sector.
For a deeper, data-driven look at how these factors translate into valuation metrics, you might explore the analytics on ValueRay to see where the risk-adjusted upside may lie.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income: 325.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -1.95 > 1.0 |
| NWC/Revenue: 4.70% < 20% (prev 4.52%; Δ 0.18% < -1%) |
| CFO/TA 0.06 > 3% & CFO 1.01b > Net Income 325.8m |
| Net Debt (8.26b) to EBITDA (1.59b): 5.20 < 3 |
| Current Ratio: 1.67 > 1.5 & < 3 |
| Outstanding Shares: last quarter (156.9m) vs 12m ago 0.45% < -2% |
| Gross Margin: 11.81% > 18% (prev 0.11%; Δ 1169 % > 0.5%) |
| Asset Turnover: 396.7% > 50% (prev 408.1%; Δ -11.42% > 0%) |
| Interest Coverage Ratio: 2.09 > 6 (EBITDA TTM 1.59b / Interest Expense TTM 396.0m) |
Altman Z'' 1.87
| A: 0.17 (Total Current Assets 7.61b - Total Current Liabilities 4.55b) / Total Assets 18.35b |
| B: 0.09 (Retained Earnings 1.74b / Total Assets 18.35b) |
| C: 0.05 (EBIT TTM 829.4m / Avg Total Assets 16.37b) |
| D: 0.13 (Book Value of Equity 1.73b / Total Liabilities 13.78b) |
| Altman-Z'' Score: 1.87 = BBB |
Beneish M -2.97
| DSRI: 1.05 (Receivables 2.93b/2.52b, Revenue 64.96b/58.76b) |
| GMI: 0.96 (GM 11.81% / 11.37%) |
| AQI: 1.02 (AQ_t 0.29 / AQ_t-1 0.28) |
| SGI: 1.11 (Revenue 64.96b / 58.76b) |
| TATA: -0.04 (NI 325.8m - CFO 1.01b) / TA 18.35b) |
| Beneish M-Score: -2.97 (Cap -4..+1) = A |
What is the price of PFGC shares?
Over the past week, the price has changed by -0.35%, over one month by +10.25%, over three months by -0.91% and over the past year by +8.15%.
Is PFGC a buy, sell or hold?
- StrongBuy: 7
- Buy: 3
- Hold: 6
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the PFGC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 119.7 | 23.3% |
| Analysts Target Price | 119.7 | 23.3% |
| ValueRay Target Price | 109.7 | 13% |
PFGC Fundamental Data Overview February 03, 2026
P/E Forward = 18.9394
P/S = 0.2431
P/B = 3.3656
P/EG = 0.6659
Revenue TTM = 64.96b USD
EBIT TTM = 829.4m USD
EBITDA TTM = 1.59b USD
Long Term Debt = 5.64b USD (from longTermDebt, last quarter)
Short Term Debt = 337.5m USD (from shortTermDebt, last quarter)
Debt = 8.30b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.26b USD (from netDebt column, last quarter)
Enterprise Value = 23.23b USD (14.97b + Debt 8.30b - CCE 38.1m)
Interest Coverage Ratio = 2.09 (Ebit TTM 829.4m / Interest Expense TTM 396.0m)
EV/FCF = 44.42x (Enterprise Value 23.23b / FCF TTM 523.0m)
FCF Yield = 2.25% (FCF TTM 523.0m / Enterprise Value 23.23b)
FCF Margin = 0.81% (FCF TTM 523.0m / Revenue TTM 64.96b)
Net Margin = 0.50% (Net Income TTM 325.8m / Revenue TTM 64.96b)
Gross Margin = 11.81% ((Revenue TTM 64.96b - Cost of Revenue TTM 57.29b) / Revenue TTM)
Gross Margin QoQ = 11.81% (prev 11.82%)
Tobins Q-Ratio = 1.27 (Enterprise Value 23.23b / Total Assets 18.35b)
Interest Expense / Debt = 1.26% (Interest Expense 104.4m / Debt 8.30b)
Taxrate = 22.96% (27.9m / 121.5m)
NOPAT = 638.9m (EBIT 829.4m * (1 - 22.96%))
Current Ratio = 1.67 (Total Current Assets 7.61b / Total Current Liabilities 4.55b)
Debt / Equity = 1.82 (Debt 8.30b / totalStockholderEquity, last quarter 4.57b)
Debt / EBITDA = 5.20 (Net Debt 8.26b / EBITDA 1.59b)
Debt / FCF = 15.80 (Net Debt 8.26b / FCF TTM 523.0m)
Total Stockholder Equity = 4.41b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.99% (Net Income 325.8m / Total Assets 18.35b)
RoE = 7.39% (Net Income TTM 325.8m / Total Stockholder Equity 4.41b)
RoCE = 8.26% (EBIT 829.4m / Capital Employed (Equity 4.41b + L.T.Debt 5.64b))
RoIC = 6.42% (NOPAT 638.9m / Invested Capital 9.95b)
WACC = 5.95% (E(14.97b)/V(23.27b) * Re(8.71%) + D(8.30b)/V(23.27b) * Rd(1.26%) * (1-Tc(0.23)))
Discount Rate = 8.71% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.38%
[DCF Debug] Terminal Value 88.26% ; FCFF base≈590.0m ; Y1≈727.8m ; Y5≈1.24b
Fair Price DCF = 173.8 (EV 35.51b - Net Debt 8.26b = Equity 27.25b / Shares 156.8m; r=5.95% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 43.58 | EPS CAGR: 21.41% | SUE: -0.33 | # QB: 0
Revenue Correlation: 84.94 | Revenue CAGR: 7.90% | SUE: 1.33 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.97 | Chg30d=-0.001 | Revisions Net=-1 | Analysts=14
EPS current Year (2026-06-30): EPS=4.98 | Chg30d=+0.011 | Revisions Net=+1 | Growth EPS=+11.2% | Growth Revenue=+7.0%
EPS next Year (2027-06-30): EPS=6.28 | Chg30d=+0.025 | Revisions Net=+0 | Growth EPS=+25.9% | Growth Revenue=+6.6%